Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:16 PM
Ignite Modification Date:
2025-12-24 @ 11:16 PM
NCT ID:
NCT05200156
Eligibility Criteria:
Inclusion Criteria:
1. Adult Patients from 18 to 65 years.
2. Gender: both males and females (age and sex matched in both groups).
3. Patients diagnosed with NAFLD via ultrasound (hepatic steatosis observation on ultrasound).
4. Treatment free from choline supplementation for the past 3 months prior starting the therapeutic regimen.
Exclusion Criteria:
1. Other liver diseases as viral hepatitis (B or C)
2. Alcohol consumption more than 40 g per week for the past 12 months, and life-time cumulative consumption more than 100 kg.
3. Autoimmune liver disease
4. Malignancy of any nature.
5. Any systemic failure (cardiovascular, renal or respiratory)
6. Patients with major psychiatric illness.
7. Pregnant or lactating women.
8. Diabetes mellitus .
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
65 Years
Study:
NCT05200156
Study Brief:
Protocol Section:
NCT05200156